ANATHROMB Trademark

Trademark Overview

On Friday, June 3, 2016, a trademark application was filed for ANATHROMB with the United States Patent and Trademark Office. The USPTO has given the ANATHROMB trademark a serial number of 79192710. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, September 29, 2023. This trademark is owned by AOP Orphan Pharmaceuticals AG. The ANATHROMB trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of myeloproliferative diseases
anathromb

General Information

Serial Number79192710
Word MarkANATHROMB
Filing DateFriday, June 3, 2016
Status709 - CANCELLED - SECTION 71
Status DateFriday, September 29, 2023
Registration Number5158542
Registration DateTuesday, March 14, 2017
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 27, 2016

Trademark Statements

Description of MarkThe mark consists of the wording "ANATHROMB" with the letters "ANA" in grey and the letters "THROMB" in purple; below the wording are three sets of bars from left to right, the first two in grey and the third in purple.
Goods and ServicesPharmaceutical preparations for the treatment of myeloproliferative diseases
Indication of Colors claimedThe color(s) grey and purple is/are claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, September 29, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAOP Orphan Pharmaceuticals GmbH
Party Type30 - Original Registrant
Legal Entity Type11 - Company
AddressAT
Party NameAOP Orphan Pharmaceuticals AG
Party Type20 - Owner at Publication
Legal Entity Type11 - Company
AddressAT
Party NameAOP Orphan Pharmaceuticals AG
Party Type10 - Original Applicant
Legal Entity Type11 - Company
AddressAT

Trademark Events

Event DateEvent Description
Friday, October 14, 2016ASSIGNED TO EXAMINER
Saturday, October 1, 2016SN ASSIGNED FOR SECT 66A APPL FROM IB
Wednesday, October 12, 2016LIMITATION FROM ORIGINAL APPLICATION ENTERED
Friday, October 14, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, October 17, 2016NON-FINAL ACTION WRITTEN
Tuesday, October 18, 2016APPLICATION FILING RECEIPT MAILED
Tuesday, October 18, 2016NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, October 28, 2016REFUSAL PROCESSED BY MPU
Friday, October 28, 2016NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, November 14, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, November 14, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 15, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, November 18, 2016REFUSAL PROCESSED BY IB
Wednesday, November 16, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 7, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 27, 2016PUBLISHED FOR OPPOSITION
Tuesday, December 27, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 14, 2017REGISTERED-PRINCIPAL REGISTER
Wednesday, June 14, 2017FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Wednesday, June 21, 2017FINAL DISPOSITION PROCESSED
Wednesday, June 21, 2017FINAL DISPOSITION NOTICE SENT TO IB
Saturday, July 8, 2017FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, November 26, 2021CHANGE OF NAME/ADDRESS REC'D FROM IB
Saturday, December 18, 2021CHANGE OF NAME/ADDRESS REC'D FROM IB
Monday, March 14, 2022COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, September 29, 2023CANCELLED SECTION 71
Friday, June 14, 2024TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, June 28, 2024INVALIDATION PROCESSED
Friday, June 28, 2024TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

Related Keywords

anathromb diseases myeloproliferative treatment preparations pharmaceutical